Live · updated 6 minutes ago · 26 stories in 24h

← Stream
Stocks & Indices Unverified First seen

Sellas Life Sciences shares jump on leukemia vaccine trial result

Investor's Business Daily reported that Sellas Life Sciences shares rose sharply early Tuesday after its experimental cancer vaccine cut the risk of death for leukemia patients. The post states the shares catapulted 220%. No other sources or confirmations are included.

Why “Unverified”

  • Reported by Investor's Business Daily alone, with no second source or primary confirmation yet

1 independent source group across 1 post · evidence score 52/100. How labels work

What the sources claim

  1. Sellas Life Sciences shares rose 220% after its experimental cancer vaccine reduced the risk of death in leukemia patients.

    “Sellas Life Sciences catapulted early Tuesday after its experimental cancer vaccine cut the risk of death for leukemia patients.”
    Investor's Business Daily

Sources

More in Stocks & Indices

All Stocks & Indices stories →

Embed this page

Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-17 14:30 UTC. Labels are computed from the sources, not by the model.